Quick Answer
Fulgent Genetics, Inc. reported Operating Income of -$91.10 million for fiscal year 2025.
Fulgent Genetics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$91.10M | -23.2% |
| 2024 | -$73.92M | +62.2% |
| 2023 | -$195.53M | -209.5% |
| 2022 | $178.53M | -73.6% |
| 2021 | $675.95M | +133.0% |
| 2020 | $290.16M | +67893.9% |
| 2019 | -$428.0K | +91.6% |
| 2018 | -$5.07M | -45.6% |
| 2017 | -$3.48M | -479.3% |
| 2016 | $918.0K | +118.3% |
| 2015 | -$5.01M | -406.3% |
| 2014 | -$990.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.35M | +10.1% | +22.1% |
| June 30, 2025 | -$19.71M | -4.3% | +0.4% |
| March 31, 2025 | -$19.80M | +9.2% | -15.9% |
| September 30, 2024 | -$17.08M | -8080.8% | +9.7% |
| June 30, 2024 | -$18.91M | +4.5% | +13.3% |
| March 31, 2024 | -$21.80M | +12.2% | -10286.0% |
| September 30, 2023 | $214.0K | -39.2% | +101.1% |
| June 30, 2023 | -$19.80M | -254.7% | +20.2% |
- Fulgent Genetics, Inc. showed a decrease of -23.2% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, Fulgent Genetics, Inc.’s operating income has declined by 9101.6% (from -$990.0 thousand to -$91.10 million).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: